Skip to content

Hand Held Nitrous Oxide Delivery Device

Safety and Efficacy of Hand Held Nitrous, a Device That Delivers 16 Grams of Nitrous Oxide Over 120 Seconds of Inhalation Time.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02119403
Acronym
HHN
Enrollment
250
Registered
2014-04-21
Start date
2013-07-31
Completion date
2014-12-31
Last updated
2014-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Minimal Sedation nitrous oxide

Brief summary

To study the safety and efficacy of Hand Held Nitrous. A device that delivers 120 seconds of up to 72% nitrous oxide and ambient air.

Detailed description

This study assesses the Hand Held Nitrous Oxide Deliver Device which is intended to be used in nitrous oxide sedation systems by delivering a limited 16 grams of nitrous oxide over a total of 120 seconds of inhalation time. The device creates short term minimal sedation by delivering a maximum 72% USP grade nitrous oxide / 28 % ambient air combination which quickly drops to under 33% nitrous oxide / 67% ambient air in 60 seconds and stays steady until all the gas is expelled.

Interventions

OTHERThere are no other inteventions.

This device gives patients the opportunity to receive nitrous oxide where no such opportunity exists. There is no other intervention available that creates immediate short term minimal sedation.

Sponsors

Strata Medical Innovations
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient undergoing a painful office procedure or exam

Exclusion criteria

* Women that are Pregnant * Children under three years of age

Design outcomes

Primary

MeasureTime frameDescription
This study measures the types of complications (if any) associated with the use of small set amount of nitrous oxide.The patient is under observation for the length of the procedure or until baseline parameters are met (under 10 minutes). No followup is required.This is a short acting device that delivers a small amount of nitrous oxide. The patient responds quickly and recovers quickly (approximately 6 minutes).

Countries

United States

Contacts

Primary ContactMark W Aldana, B.S. MBA
806-787-0756

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026